Skip to main content
NANOVIRICIDES, INC. logo

NANOVIRICIDES, INC. — Investor Relations & Filings

Ticker · NNVC ISIN · US6300873022 LEI · 5493003CK9Y2H0OORR73 US Professional, scientific and technical activities
Open in API
Filings indexed 536 across all filing types
Latest filing 2020-07-20 Major Shareholding Noti…
Country US United States of America
Listing US NNVC

About NANOVIRICIDES, INC.

https://www.nanoviricides.com/

NanoViricides, Inc. is a clinical-stage biopharmaceutical company developing a novel class of nanomedicine-based antiviral therapeutics. The company's proprietary platform technology creates "nanoviricides," which are designed to be broad-spectrum drugs that viruses cannot easily evade through mutation. The technology is biomimetic, mimicking the host cell receptors that viruses use for entry. A nanoviricide is engineered to attract and bind to a virus particle, subsequently trapping and dismantling it to neutralize the threat. The company's development pipeline targets a wide range of viral infections, including respiratory viruses such as RSV, influenza, and coronaviruses, as well as herpesviruses (shingles, cold sores), HIV, and hemorrhagic fever viruses.

Recent filings

Filing Released Lang Actions
ACQUISITION OF BENEFICIAL OWNERSHIP
Major Shareholding Notification
2020-07-20 English
FORM 8-K
Regulatory Filings
2020-07-13 English
NanoViricides Raises $11.5M-Underwritten Offering
Regulatory Filings Classification · 98% confidence The document is a press release announcing the completion of an underwritten public offering of common stock by NanoViricides, Inc. It details the gross proceeds, the number of shares issued, the underwriters involved, and the intended use of funds. While it mentions that a Form 8-K will be filed, the document itself is a corporate announcement regarding a capital raise. According to the filing definitions, announcements regarding fundraising and financing activities fall under the 'Capital/Financing Update' (CAP) category.
2020-07-13 English
424B5
Regulatory Filings
2020-07-09 English
NanoViricides Prices $10million Public Offering
Capital/Financing Update Classification · 95% confidence The document is a press release announcing the pricing of a $10 million public offering of common stock by NanoViricides, Inc. It details the number of shares, the price per share, the use of proceeds, and the involvement of underwriters. This falls under the category of capital raising and financing activities. While it mentions an RNS header, the content is a substantive announcement of a capital transaction rather than a mere report publication notice or a general regulatory filing.
2020-07-09 English
424B5
Regulatory Filings
2020-07-09 English

Browse filings by year

21 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.